OUR EXPERT NETWORK

• The Hidden Physics Of RNA-LNPs: Tuning RNA Encapsulation For Potency And Safety

  Why LNPs that look identical behave differently in cells. This piece reveals how mixing physics and payload uniformity shape RNA potency, safety, dosing, and manufacturability—beyond size alone.

• Benchmarking RNA Delivery Performance: Toward Standardized Metrics For Translational Success

  As RNA pipelines mature, delivery success demands shared benchmarks. This article proposes standardized, stage-specific metrics to compare platforms, guide optimization, and strengthen regulatory confidence.

• 2026 RNA Investment Landscape: Recent Deals, IPOs, And Venture Trends

  As RNA investing matures, capital is flowing toward delivery, durability, and regulatory credibility. This column breaks down the deals, IPO signals, and venture theses shaping RNA’s 2026 winners—and why.

• Overcoming Lung Tumor Barriers: Nanoparticle Delivery Strategies For Pulmonary Cancers

  Solid lung tumors have a complex tumor microenvironment that creates barriers to drug delivery. Nanoparticle therapies can overcome these challenges.

• Advances In Endometrial-Targeted Drug Delivery In Women's Health

  Johns Hopkins investigators discuss gaps in women’s health research and how their work addresses endometrial dysfunction and infertility through precision nanomedicine.